CTRI/2022/09/045260尚未招募未知
Primary Objective: To evaluate the in-vivo efficacy and safety of Skin care formulation in terms of tan reduction, reduction in pigmentation and skin smoothness on healthy male and female subjects.Secondary Objective: To evaluate the in-vivo efficacy and safety of Skin care formulation in terms of Skin brightness and Skin even tone on healthy male and female subjects.
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- SkinQ
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Indian male & female subjects.
- •2.Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup).
- •3.Between 18 and 45 years of age.
- •4.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.).
- •5.Having tanned minimal forehead.
- •6.Having uneven skin tone with pigmentation (Acne PIH / Melasma)
排除标准
- •1.For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
- •2.For Male: Shave beard 1day prior before visit
- •3.Having refused to give his/her assent by not signing the consent form
- •4.Taking part in another study liable to interfere with this study
- •5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
- •6.Having acne prone skin.
- •7.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
- •8.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
- •9.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- •10.Having cutaneous hypersensitivity.
- •11.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
- •12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
- •13.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
- •14.Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)
- •15.Refusing to follow the restrictions below during the study: For Females: Do not take part in any family planning activities leading to pregnancy and breastfeeding. Do not take part in another study liable to interfere with this study. Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). Do not change their cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit During the study: Do not use other cosmetic products than the tested products to the studied areas. The day of the measurements: No test product must be used (only face cleaned with water is accepted)
- •16.Having started, changed or interrupted one hormonal treatment (hormonal contraception, Hormone Replacement Therapy) during the past 3 months.
- •17.Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months.
- •18.Having consumed caffeine-based products (coffee, cola, tea, ââ?¬Â¦), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements
- •19.Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoÃ?¯n, amiodarone, metals, minocyclineââ?¬Â¦) in the previous 6 months
- •20.Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta caroteneââ?¬Â¦)
- •21.Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask ââ?¬Â¦) or having applied self-tanning products in the week preceding the start of the study
- •22.Having applied products with a depigmenting/ whitening action (hydroquinone or derivatesââ?¬Â¦) in the 4 weeks preceding the start of the study.
- •23.Having undergone physical and/o
研究者
相似试验
已完成
Unknown
Safety and efficacy assessment of Product on skiCTRI/2023/03/050915DPKA UNIVERSAL CONSUMER VENTURES PRIVATE LIMITED52
已完成
不适用
Safety and efficacy assessment of Product on skiCTRI/2022/09/045184SkinQ36
尚未招募
不适用
Safety and efficacy of Skin care formulatioCTRI/2022/04/042231Kama Ayurveda Pvt Ltd
尚未招募
不适用
Safety and efficacy assessment of Product on skiCTRI/2022/09/045309SkinQ
尚未招募
不适用
Evaluation of Safety and Efficacy of ProductCTRI/2022/05/042724Kama Ayurveda Pvt Ltd